Log In
BCIQ
Print this Print this
 

SXL01

  Manage Alerts
Collapse Summary General Information
Company SeleXel
Description 
Molecular Target Androgen receptor
Mechanism of ActionGene silencing
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationProstate cancer
Indication DetailsTreat castration-resistant prostate cancer (CRPC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today